Medical News

RSS

PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that clinical data with PMX-60056 were presented at the American Heart Association's Arteriosclerosis, Thrombosis, and Vascular Biology Meeting in Chicago on April 28, 2011.

4 May 2011

SARcode reports encouraging data from SAR 1118 Phase 2 dry eye trial

SARcode Corporation presented data today for their lead investigational molecule, SAR 1118. In a Phase 2 dry eye trial, subjects receiving SAR 1118 demonstrated a reduction in corneal staining, increased tear production, and improved visual-related function as compared to placebo. These data were part of the scientific program of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held in Fort Lauderdale, Florida.

4 May 2011

'Big cleanout' no cure for hoarding

Kaiser Health News's Peggy Girshman writes: "If basic cable is any indication we have a fascination with hoarding. 'We all love a good train wreck' says Mark Odom, clinical consultant to the Orange County (Calif.) Task Force on Hoarding.

4 May 2011

Cancers use body's own defences to resist drugs

CANCER RESEARCH UK scientists have discovered that tumours are able to recruit part of the body's defence system to protect them from the effect of a drug designed to block the supply of blood to the tumour.

4 May 2011

pSivida presents data of ILUVIEN Phase 3 trial in Diabetic Macular Edema at ARVO 2011

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced the presentation of new data from the completed 36-month FAME Study of ILUVIEN for the treatment of Diabetic Macular Edema at the 2011 ARVO Annual Meeting.

4 May 2011

Thoratec reports $99.5 million revenue for first quarter 2011

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that revenues from continuing operations in the first quarter of fiscal 2011 were $99.5 million versus revenues of $99.3 million in the same period a year ago.

4 May 2011

iOWH, Center for World Health and Medicine partner to combat childhood diarrhea

The Center for World Health and Medicine at Saint Louis University and the Institute for OneWorld Health have established a joint research agreement to develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children under age 5.

4 May 2011

Top-line results from Lymphoseek NEO3-09 Phase 3 study in breast cancer, melanoma

Neoprobe Corporation, a diversified developer of innovative oncology diagnostic products, today announced top-line results from its Lymphoseek NEO3-09 study.

4 May 2011

Viewpoints: Dem representatives on health spending; Star Tribune praises IPAB; NY Times on stem cells

When the debate over the fiscal 2012 budget began, the country — or, more accurately, the media — was focused on Rep. Paul Ryan's proposal. Introduced on behalf of the Republican House majority, our colleague's plan puts the interests of wealthy corporations first by slashing Medicare and Medicaid and spending trillions on a new corporate tax cut. Indeed, cutting is all it seems to do. ... That's not a jobs plan — that's an economic death sentence.

4 May 2011

Exercise linked to improved lung status in children with cystic fibrosis

A small Johns Hopkins Children's Center study of children and teens with cystic fibrosis shows that simple exercise, individually tailored to each patient's preference and lifestyle, can help improve lung function and overall fitness.

4 May 2011

Researchers develop novel spinal cord injury treatment

Rutgers researchers have developed an innovative new treatment that could help minimize nerve damage in spinal cord injuries, promote tissue healing and minimize pain.

4 May 2011

WWP2 protein appears to play a key role in tumor survival

A protein known as WWP2 appears to play a key role in tumor survival, a research team headed by a scientist at The University of Texas MD Anderson Cancer Center reports in an advance online publication of Nature Cell Biology.

4 May 2011

3M launches new Mobile Physician Solution

New mobile technology introduced today by 3M makes it easy for physicians to manage their daily schedule, review patient information, dictate progress notes, and log accurate charges all on a single mobile device in the palm of their hand.

4 May 2011

Tenet net operating revenues increase 7.1% to $2.506 billion for first quarter 2011

Tenet Healthcare Corporation today reported adjusted EBITDA of $379 million for the first quarter ended March 31, 2011, an increase of $81 million, or 27.2 percent, compared to $298 million for the first quarter of 2010.

4 May 2011

SBS explores ‘superbugs’ on Insight Tuesday 10th May

Since the discovery of penicillin in the early twentieth century, antibiotics have fought infections and diseases that were once life threatening. But over time, many bacteria have become resistant to these drugs and patients are increasingly at risk.

3 May 2011